香港兒童醫院致力推動科研發展，與大學緊密合作，從事各種 兒科和遺傳疾病的基本和轉化研究，並參與臨床試驗，以開拓 創新治療方法，提升臨床服務質素，更期望能尋求突破性醫學 發現，為病人帶來更深遠裨益。 為全面支援科研活動及發展，本院設有專屬設施如科研實驗 室、臨床研究中心及數據中心，還有專責科研事務的委員會及 辦公室。 本院獲醫療衞生研究基金撥款進行委託兒科研究項目。此外， 我們獲陳廷驊基金會捐款成立「陳廷驊基金會臨床科研獎學金 計劃」，培育新一代科研人才。 本院參與跨國性第三期臨床試 驗，研究基因治療對杜興氏肌 肉萎縮症的成效及安全性，是 香港首次進行基因治療的臨床 試驗。一名參加者正按照研究 的規定接受輸注。 HKCH is part of a multinational phase III clinical trial to study the efficacy and safety of using gene therapy to treat Duchenne muscular dystrophy, which is the first gene therapy trial in Hong Kong. A participant is undergoing infusion according to study protocol. Promoting research is one of the missions of HKCH. We collaborate closely with universities in conducting basic and translational research on paediatric and genetic diseases and take part in clinical trials, aiming to stimulate innovative clinical practices that can benefit patient care, and discover medical breakthroughs with far-reaching impact. Besides purpose-built infrastructure including research laboratories, clinical trial centre and data centre, there are dedicated research committees and office to fully support the research activities and development at HKCH. Designated funding has been granted by the Health & Medical Research Fund for HKCH to conduct commissioned paediatric research projects. To nurture the next generation of medical scientists, we also set up The D. H. Chen Foundation Clinical Research Fellowship Program with the generous donation from the Foundation. 推動科研 尋求醫學突破 Promote Research for Medical Breakthroughs 53 Hong Kong Children’s Hospital 5th Anniversary Commemorative Album 香港兒童醫院 五周年紀念特刊 追求卓越 Pursuit of Excellence
RkJQdWJsaXNoZXIy MjQwOTYxOQ==